A historic milestone
One of our proudest advocacy successes is the approval of Resolution WHA 67.9 by the World Health Organization (WHO).
This Resolution is the only international resolution focusing solely on psoriasis. It is particularly significant because it confirms that psoriasis:
- Is a chronic, painful, disfiguring and disabling non-communicable disease, without a cure;
- Has physical as well as psycho-social and socio-economic consequences;
- Is connected to psoriatic arthritis and increases the risk of various co-morbid diseases;
- Can lead to immense, needless suffering due to insufficient access to healthcare.
Because of this, the Resolution is a historic milestone for the global psoriasis community.
You can read the entire Resolution here.
The road to resolution WHA 67.9
A decade ago, psoriasis was absent from the international agenda. Very few policy-makers had ever heard about the disease. The WHO website provided almost no info on it. Few took psoriasis seriously.
So we set ourselves an ambitious target: to get the WHO to approve an official Resolution on psoriasis. This would be a powerful signal to states around the world to take action on psoriasis.
We put together a dedicated advocacy team. We gained the support of IAPO (the International Alliance of Patient Organizations) and Panama, Argentina, Qatar and Ecuador as champion states. Policy papers were written and submitted. In statements at WHO meetings, we argued for delegates to take a closer look at psoriasis. At the 66th and 67th World Health Assembly, we arranged strategic psoriasis side events. Things sped up: in 2013, the WHO Executive Board unanimously approved putting forward our Resolution proposal to the Assembly.
In May 2014, we achieved our goal: the 67th World Health Assembly officially accepted Resolution WHA 67.9.